TRIESTE, LEOPOLDO
 Distribuzione geografica
Continente #
NA - Nord America 8.977
EU - Europa 5.988
AS - Asia 4.672
SA - Sud America 904
Continente sconosciuto - Info sul continente non disponibili 151
AF - Africa 128
OC - Oceania 50
Totale 20.870
Nazione #
US - Stati Uniti d'America 8.474
IT - Italia 2.147
SG - Singapore 1.716
RU - Federazione Russa 1.199
CN - Cina 1.146
GB - Regno Unito 745
BR - Brasile 691
VN - Vietnam 633
DE - Germania 451
CA - Canada 297
UA - Ucraina 290
HK - Hong Kong 235
BD - Bangladesh 218
FR - Francia 190
SE - Svezia 164
KR - Corea 163
DK - Danimarca 151
IN - India 138
NL - Olanda 121
FI - Finlandia 95
PL - Polonia 84
AR - Argentina 81
IE - Irlanda 76
MX - Messico 63
ES - Italia 62
JP - Giappone 59
TR - Turchia 56
ZA - Sudafrica 48
ID - Indonesia 47
AU - Australia 45
EC - Ecuador 42
BE - Belgio 34
PH - Filippine 34
IQ - Iraq 32
AT - Austria 30
CR - Costa Rica 30
PK - Pakistan 30
CO - Colombia 26
MY - Malesia 26
PT - Portogallo 24
IL - Israele 22
CH - Svizzera 21
EU - Europa 20
TW - Taiwan 19
LT - Lituania 17
GT - Guatemala 16
HN - Honduras 16
NI - Nicaragua 15
RO - Romania 15
TN - Tunisia 15
TT - Trinidad e Tobago 15
MA - Marocco 14
PY - Paraguay 14
PE - Perù 13
VE - Venezuela 13
SA - Arabia Saudita 12
SK - Slovacchia (Repubblica Slovacca) 12
UZ - Uzbekistan 12
CL - Cile 11
CW - ???statistics.table.value.countryCode.CW??? 11
JO - Giordania 11
SV - El Salvador 11
JM - Giamaica 10
PR - Porto Rico 10
KE - Kenya 9
AZ - Azerbaigian 7
EG - Egitto 7
SN - Senegal 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
BG - Bulgaria 6
CZ - Repubblica Ceca 6
GP - Guadalupe 6
GR - Grecia 6
LV - Lettonia 6
SY - Repubblica araba siriana 6
UY - Uruguay 6
BY - Bielorussia 5
CY - Cipro 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
IR - Iran 5
KZ - Kazakistan 5
LU - Lussemburgo 5
NP - Nepal 5
NZ - Nuova Zelanda 5
OM - Oman 5
TH - Thailandia 5
DZ - Algeria 4
SI - Slovenia 4
AO - Angola 3
BO - Bolivia 3
DM - Dominica 3
NG - Nigeria 3
PS - Palestinian Territory 3
SC - Seychelles 3
SR - Suriname 3
UG - Uganda 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
Totale 20.713
Città #
Dallas 1.869
Singapore 928
Ashburn 610
San Jose 588
Beijing 423
Council Bluffs 418
Chandler 375
Woodbridge 342
Southend 341
Houston 270
Milan 265
Pisa 224
Hong Kong 218
Rome 209
Moscow 185
San Mateo 175
Los Angeles 173
Ho Chi Minh City 172
Ann Arbor 170
The Dalles 157
New York 153
Jacksonville 143
Hanoi 124
Fairfield 123
Santa Clara 117
Dearborn 106
Seattle 106
Daejeon 97
Boardman 91
Cambridge 90
Wilmington 90
Falls Church 87
Phoenix 87
São Paulo 82
Hefei 77
Beauharnois 70
Lauterbourg 69
Dublin 67
Warsaw 67
Dong Ket 65
Seoul 62
Montreal 61
Stevenage 61
Buffalo 59
Portsmouth 59
Brooklyn 57
Florence 56
Lawrence 55
Orem 54
Fremont 49
Denver 48
London 43
Tokyo 43
Atlanta 42
Chennai 42
Bologna 41
Munich 41
Stockholm 38
Salerno 37
Columbus 34
Chicago 33
Figino 33
Helsinki 33
Naples 33
Johannesburg 31
Serra 31
Turin 31
Genoa 30
Poplar 30
Mexico City 29
Frankfurt am Main 28
Haiphong 28
Paris 27
Toronto 27
Amsterdam 26
Buti 25
Montréal 25
Lucca 23
Redwood City 23
Ankara 22
Old Bridge 21
San José 21
Boston 20
Nuremberg 20
Ottawa 20
Rio de Janeiro 20
San Francisco 19
Mumbai 17
Trento 17
Da Nang 16
Quito 16
San Diego 16
Charlotte 15
Dhaka 15
Guayaquil 15
Livorno 15
Managua 15
Querétaro 15
Vienna 15
Hamburg 14
Totale 11.915
Nome #
Nutri-Score and Food Perception: Insights from an Italian Study 824
On Robots and Insurance 589
The Effect of using Serifs in Brand Names on Luxury Perception 588
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 544
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 435
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 417
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 398
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 383
How colour saturation accelerates purchase behaviour, and influences food choice: 359
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 345
A systematic literature review of the economic impact of ankylosing spondylitis 334
Is EEG Suitable for Marketing Research? A Systematic Review 319
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 315
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 308
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 308
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 305
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 304
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 299
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 299
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 297
Natural and man-made disasters: challenges and international perspectives for insurance 296
Assessing the value of the use of diagnostic technology: trade offs for GPs 291
Columbus' egg and the engineer's effect in forecasting solutions adoption 287
The influence of parental Dietary Behaviors, food literacy and chronotype on Children’s eating habits and psychometric factors 286
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 284
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 284
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 282
Being a caregiver of a Behçet’s syndrome patient: challenges and perspectives during a complex journey 281
Are drug procurement procedure and award criteria in EU hospital setting standardized and do they take into account effective supply quality? 279
TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol 278
Health information technologies in systemic lupus erythematosus: focus on patient assessment 275
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients’ care pathway 274
WEB SURVEY AND FOCUS GROUPS EXPLORING KNOWLEDGE, NEEDS AND EXPECTATIONS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS 273
Taste Your Consumer Audience. How Sensory Expertise Influences Food Choice 269
Which indicators for measuring the daily physical activity? An overview on the challenges and technology limits for Telehealth applications 269
Asessment And Simulation of Costs And QOL For Sublingual Immunotherapy In Paediatric Asthma Vs Placebo: Preliminary Data 263
KNOWLEDGE, USE AND DESIDERATA ABOUT INFORMATION AND COMMUNICATION TECHNOLOGIES SYSTEMS FOR SYSTEMIC LUPUS ERYTHEMATOSUS. PRELIMINARY RESULTS FROM THE INTEGRATE PILOT PROJECT 260
Conseguenze cliniche ed economiche dello switch ai biosimilari dell’Infliximab nei pazienti reumatologici in Toscana 257
The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS) 255
Cost analysis of technological vs. conventional upper limb rehabilitation for patients with neurological disorders: an Italian real-world data case study 253
Management and Treatment of Type 1 And 2 Diabetes: State of Art 251
Systemic vasculitis: how little we know about their societal and economic burden 248
Raiders of Lost Value 240
The definition of a new organizational, technology-based, integrated home care model 238
The nature, causes, and effects of skepticism on technology diffusion 237
Consideration on the Accuracy of Watch for Physical Activity Tracker 237
P56 Early Health Technology Assessment to Guide Introduction of Novel Technology into the Market: The Vostars System Case Study 232
Razionale e strumenti della valutazione economica in sanità 231
The economic impact of gout: a systematic literature review 230
Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4) 229
Switching from infliximab‐originator to infliximab‐biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 227
Food literacy and food purchase behaviour 224
The cost of illness of ultra-rare Cryopyrin Associated Periodic Syndromes (CAPS) in Italy: Preliminary results from the Radicea project 221
L’evoluzione della distribuzione del farmaco e dell'erogazione dei servizi in farmacia 212
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 211
Natura e ruolo degli indicatori nella logistica farmaceutica 211
Telemonitoring in Cystic Fibrosis: A 4-year Assessment and Simulation for the Next 6 Years 198
The organizational dimension in rare and complex diseases care management: an application of RarERN Path© methodology in ataxias, dystonia and phenylketonuria 194
Analysis and Synthesis in Information Processing and Knowledge Creation 193
State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases 190
Innovazione tecnologica, dinamica del contesto economico e logistica in sanità 189
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 187
Farmaci per le patologie autoimmuni. Traiettorie di trattamento nell’artrite reumatoide 186
Valutazione dei risultati di una gara 182
EYE ON PACK. Visual search strategies in food choice 179
Managing customization, brand consistency, and identity dynamic trade-offs: opportunities and chaos 178
Finanziamenti pubblici 178
Propedeutica alle scienze Sperimentali. Introduzione al metodo scientifico e all'inferenza statistica. 172
Strumenti per favorire gli investimenti e la competitività delle imprese 172
Le start up 171
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 171
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 163
Valutazione dell’attività di malattia nei periodi di interruzione del trattamento con farmaci biologici modificanti la malattia reumatica in pazienti con artrite reumatoide 156
Industria 4.0 e Digitalizzazione 133
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study 133
Nonlinear trade-offs in customer acquisition and retention 110
Validazione degli algoritmi di selezione dei pazienti reumatologici nei database amministrativi toscani e traiettorie di aderenza ai farmaci biologici modificanti la malattia nell’artrite reumatoide 74
null 63
The Role of Digital Tools and Their Implementation Within Patient Care Pathways for Rare Brain Disorders: The Case of Phenylketonuria 45
Identifying needs in adult rehabilitation to support the clinical implementation of robotics and allied technologies: an Italian national survey 45
Condorcet Cycles, Contextuality, and the Emergence of Quantum-like Collective States 27
Self-produced signs in decision-making and contextual correlations 23
null 13
Totale 20.870
Categoria #
all - tutte 93.305
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.305


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022502 0 0 0 0 9 15 96 159 56 70 31 66
2022/2023841 65 85 46 134 100 136 10 47 122 28 36 32
2023/2024465 43 18 61 22 18 62 51 38 7 26 29 90
2024/20253.729 66 86 245 184 272 264 565 871 307 171 467 231
2025/20269.638 504 1.192 1.623 1.203 1.001 594 1.003 405 503 560 391 659
2026/20271.723 256 303 494 657 13 0 0 0 0 0 0 0
Totale 20.870